CARAVITA, Sergio
 Distribuzione geografica
Continente #
EU - Europa 7.179
NA - Nord America 3.881
AS - Asia 3.056
SA - Sud America 641
Continente sconosciuto - Info sul continente non disponibili 404
AF - Africa 162
OC - Oceania 4
Totale 15.327
Nazione #
US - Stati Uniti d'America 3.693
IE - Irlanda 2.895
SG - Singapore 1.488
RU - Federazione Russa 1.297
GB - Regno Unito 994
CN - Cina 667
NL - Olanda 640
IT - Italia 525
BR - Brasile 497
FR - Francia 407
VN - Vietnam 378
DE - Germania 115
CA - Canada 112
ZA - Sudafrica 112
FI - Finlandia 100
HK - Hong Kong 93
SE - Svezia 84
ID - Indonesia 72
BD - Bangladesh 65
IN - India 65
AR - Argentina 58
KR - Corea 41
MX - Messico 36
PL - Polonia 34
TR - Turchia 26
EC - Ecuador 25
IQ - Iraq 25
AT - Austria 21
JP - Giappone 20
PK - Pakistan 17
CO - Colombia 15
ES - Italia 14
MY - Malesia 14
UA - Ucraina 13
JM - Giamaica 11
PY - Paraguay 11
SA - Arabia Saudita 11
EG - Egitto 10
PE - Perù 10
UZ - Uzbekistan 10
VE - Venezuela 10
ET - Etiopia 9
NP - Nepal 9
MA - Marocco 8
PH - Filippine 8
CL - Cile 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
BG - Bulgaria 6
CR - Costa Rica 6
KE - Kenya 6
LT - Lituania 6
TT - Trinidad e Tobago 6
EU - Europa 5
IR - Iran 5
LB - Libano 5
AU - Australia 4
BO - Bolivia 4
KG - Kirghizistan 4
MD - Moldavia 4
SV - El Salvador 4
UY - Uruguay 4
AZ - Azerbaigian 3
JO - Giordania 3
KZ - Kazakistan 3
MN - Mongolia 3
PA - Panama 3
RO - Romania 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
IL - Israele 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 14.920
Città #
Dublin 2.865
Southend 840
San Jose 646
Singapore 623
Ashburn 577
Moscow 453
Council Bluffs 429
Hefei 208
Princeton 172
Ho Chi Minh City 134
New York 119
Lauterbourg 108
Los Angeles 105
Boardman 102
Johannesburg 101
Santa Clara 100
Chandler 90
Hanoi 90
The Dalles 86
Hong Kong 84
Beijing 82
Milan 77
Altamura 70
Helsinki 68
Toronto 61
Columbus 56
Washington 51
Buffalo 48
São Paulo 47
Fairfield 46
Wilmington 46
Jakarta 45
Frankfurt am Main 41
Redondo Beach 41
Dalmine 35
Chicago 33
London 33
Seoul 31
Guangzhou 30
Dallas 29
Ogden 27
Da Nang 25
Lappeenranta 25
Shanghai 24
Munich 22
Montreal 21
Amsterdam 19
Bergamo 19
Rio de Janeiro 19
Shenzhen 19
Denver 18
Nuremberg 18
Reggio Calabria 18
Rome 18
Orem 17
Tokyo 17
Mexico City 16
Atlanta 15
Boston 15
Houston 15
Pune 14
San Diego 14
Baghdad 13
Brooklyn 13
Norwalk 13
Eygelshoven 12
Phoenix 12
Warsaw 12
Woodbridge 12
Ankara 11
Curitiba 11
Hangzhou 11
San Francisco 11
Tianjin 11
Andover 10
Biên Hòa 10
Chennai 10
Dhaka 10
Haiphong 10
Poplar 10
Ribeirão Preto 10
Salt Lake City 10
Addis Ababa 9
Bologna 9
Boydton 9
Brasília 9
Cambridge 9
Guayaquil 9
Lima 9
Manchester 9
Naples 9
Seattle 9
Stockholm 9
Tashkent 9
Vienna 9
Assago 8
Erbil 8
Hounslow 8
Kingston 8
Palermo 8
Totale 9.696
Nome #
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 238
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 219
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 199
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 185
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 185
Cluster analysis of advanced invasive hemodynamics in heart failure with preserved ejection fraction 181
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 178
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 177
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 176
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 174
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 171
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 171
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 170
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 168
Blood pressure and high altitude: physiological response and clinical management 167
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 167
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 161
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 161
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 161
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 161
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 160
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 159
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 158
Right ventricular reserve in cardiopulmonary disease: a simultaneous hemodynamic and three-dimensional echocardiographic study 156
Impact of COVID-19 lockdown on exercise capacity in PAH patients 155
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 155
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 154
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 153
Interatrial Shunt Devices 153
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 152
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 151
Blood pressure at high altitude: Physiology and clinical implications 151
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 151
Discrepancy in the Diagnosis of Heart Failure With Preserved Ejection Fraction Between Supine Versus Upright Exercise Hemodynamic Testing 149
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 148
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 148
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 148
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 146
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 146
Hyperparathyroidism in celiac disease: always secondary? 146
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 146
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 144
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 144
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 143
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 142
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 142
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 140
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 140
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 139
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 138
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 138
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 138
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 137
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 136
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 136
CPET for Long COVID-19 135
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 135
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 135
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 133
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 132
Pulmonary arterial hypertension 132
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 132
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 130
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 130
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 128
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 128
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 127
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 127
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 127
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 127
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 126
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 126
Recent advances in multimodality imaging of the tricuspid valve 126
Phenotyping long COVID 125
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 124
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 122
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 122
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 121
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 121
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 120
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 119
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 118
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 118
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 118
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 117
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 116
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 116
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 116
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 115
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 115
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 112
Heart failure and anemia: Effects on prognostic variables 112
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 110
Why Do Exercise Hemodynamics Matter? 107
Determinants of Right Heart Hemodynamic Derangement in Patients With and Without Tricuspid Regurgitation 105
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 105
Invasive haemodynamic assessment in heart failure with preserved ejection fraction 103
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 103
Pulmonary Hypertension Associated with Left Heart Disease 99
Gestione clinico-strumentale e della terapia anticoagulante nel follow-up del paziente con embolia polmonare: i risultati della survey “FOLLOW-EP” promossa dall’Area Malattie del Circolo Polmonare ANMCO = Clinical-instrumental management and anticoagulant therapy in the follow-up of patients with pulmonary embolism: The results of the "FOLLOW-EP" survey promoted by the ANMCO Pulmonary Circulation Diseases Area 97
Totale 14.124
Categoria #
all - tutte 75.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.354 0 300 213 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.546 47 53 101 68 87 711 2.216 86 56 5 4 112
2024/20252.975 102 248 85 356 99 32 29 122 363 796 400 343
2025/20266.154 224 324 564 867 771 455 773 386 516 464 593 217
2026/2027319 270 49 0 0 0 0 0 0 0 0 0 0
Totale 15.327